170 related articles for article (PubMed ID: 19750990)
1. Pemphigus vulgaris: a 11-year review.
Chmurova N; Svecova D
Bratisl Lek Listy; 2009; 110(8):500-3. PubMed ID: 19750990
[TBL] [Abstract][Full Text] [Related]
2. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
3. Pemphigus vulgaris treated with adalimumab: case study.
Vojáčková N; Fialová J; Vaňousová D; Hercogová J
Dermatol Ther; 2012; 25(1):95-7. PubMed ID: 22591504
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature.
Shinkuma S; Nishie W; Shibaki A; Sawamura D; Ito K; Tsuji-Abe Y; Natsuga K; Chan PT; Amagai M; Shimizu H
Clin Exp Dermatol; 2008 Nov; 33(6):724-8. PubMed ID: 18627395
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris.
Sami N; Qureshi A; Ruocco E; Ahmed AR
Arch Dermatol; 2002 Sep; 138(9):1158-62. PubMed ID: 12224976
[TBL] [Abstract][Full Text] [Related]
6. IVIG therapy in pemphigus vulgaris has corticosteroid-sparing and immunomodulatory effects.
Svecova D
Australas J Dermatol; 2016 May; 57(2):141-4. PubMed ID: 26581165
[TBL] [Abstract][Full Text] [Related]
7. Pemphigus vulgaris: a review of treatment over a 19-year period.
Ljubojević S; Lipozencić J; Brenner S; Budimcić D
J Eur Acad Dermatol Venereol; 2002 Nov; 16(6):599-603. PubMed ID: 12482043
[TBL] [Abstract][Full Text] [Related]
8. Pemphigus in Korea: clinical manifestations and treatment protocol.
Seo PG; Choi WW; Chung JH
J Dermatol; 2003 Nov; 30(11):782-8. PubMed ID: 14684934
[TBL] [Abstract][Full Text] [Related]
9. Pemphigus vulgaris: a clinical study of 44 cases over a 20-year period.
Svecova D
Int J Dermatol; 2015 Oct; 54(10):1138-44. PubMed ID: 26394602
[TBL] [Abstract][Full Text] [Related]
10. The impact of stratifying initial dose of corticosteroids by severity of pemphigus vulgaris on long-term disease severity.
Lyakhovitsky A; Baum S; Scope A; Amichai B; Barzilai A; Rimer J; Trau H
Int J Dermatol; 2011 Aug; 50(8):1014-9. PubMed ID: 21781080
[TBL] [Abstract][Full Text] [Related]
11. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
[TBL] [Abstract][Full Text] [Related]
12. A 6-year treatment experience for pemphigus: retrospective study of 69 Chinese patients.
Bai YX; Zhang LM; Xiao T; Chen HD
Dermatol Ther; 2016; 29(2):84-7. PubMed ID: 27060935
[TBL] [Abstract][Full Text] [Related]
13. Pemphigus: analysis of 1209 cases.
Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Esmaili N; Balighi K; Hallaji Z; Barzegari M; Akhiani M; Ghodsi Z; Mortazavi H; Naraghi Z
Int J Dermatol; 2005 Jun; 44(6):470-6. PubMed ID: 15941433
[TBL] [Abstract][Full Text] [Related]
14. A rare presentation of oral pemphigus vulgaris as multiple pustules.
Rimal J; Sumanth KN; Ongole R; George T; Chatterjee S
Kathmandu Univ Med J (KUMJ); 2007; 5(4):541-5. PubMed ID: 18604092
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant high-dose intravenous immunoglobulin therapy can be easily and safely introduced as an alternative treatment in patients with severe pemphigus vulgaris: a retrospective preliminary study.
Mignogna MD; Leuci S; Fedele S; Ruoppo E; Adamo D; Russo G; Pagliuca R
Am J Clin Dermatol; 2008; 9(5):323-31. PubMed ID: 18717608
[TBL] [Abstract][Full Text] [Related]
16. Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption.
Shimanovich I; Herzog S; Schmidt E; Opitz A; Klinker E; Bröcker EB; Goebeler M; Zillikens D
Clin Exp Dermatol; 2006 Nov; 31(6):768-74. PubMed ID: 16824051
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations.
Craythorne E; du Viver A; Mufti GJ; Warnakulasuriya S
J Oral Pathol Med; 2011 Sep; 40(8):616-20. PubMed ID: 21385212
[TBL] [Abstract][Full Text] [Related]
18. Oropharyngeal pemphigus vulgaris and clinical remission: a long-term, longitudinal study.
Mignogna MD; Fortuna G; Leuci S; Ruoppo E
Am J Clin Dermatol; 2010; 11(2):137-45. PubMed ID: 20141235
[TBL] [Abstract][Full Text] [Related]
19. [Juvenile pemphigus vulgaris].
Janisson-Dargaud D; Reguiaï Z; Perceau G; Eschard C; Bernard P
Ann Dermatol Venereol; 2008 Dec; 135(12):843-7. PubMed ID: 19084695
[TBL] [Abstract][Full Text] [Related]
20. Mucous membrane manifestations of pemphigus vulgaris. A 25-year survey of 185 patients treated with corticosteroids or with combination of corticosteroids with methotrexate or heparin.
Mashkilleyson N; Mashkilleyson AL
Acta Derm Venereol; 1988; 68(5):413-21. PubMed ID: 2461025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
